$AMED
AMEDISYS INC

2014 Q3 Form 10-Q Financial Statement

#000119312514386631 Filed on October 29, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q4 2013 Q3
Revenue $300.3M $302.2M $301.3M
YoY Change -0.33% -13.71% -17.29%
Cost Of Revenue $170.2M $178.4M $175.2M
YoY Change -2.9% -9.81% -15.33%
Gross Profit $130.1M $123.8M $126.1M
YoY Change 3.17% -18.77% -19.89%
Gross Profit Margin 43.32% 40.97% 41.85%
Selling, General & Admin $107.4M $119.6M $119.8M
YoY Change -10.35% -10.81% -9.38%
% of Gross Profit 82.55% 96.61% 95.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.500M $8.700M $9.000M
YoY Change -27.78% -13.86% -9.09%
% of Gross Profit 5.0% 7.03% 7.14%
Operating Expenses $113.8M $124.4M $128.8M
YoY Change -11.65% -13.55% -9.3%
Operating Profit $16.25M -$600.0K -$154.2M
YoY Change -110.54% -107.06% -1104.08%
Interest Expense $2.990M -$1.400M $672.0K
YoY Change 344.94% -74.07% -66.09%
% of Operating Profit 18.4%
Other Income/Expense, Net -$2.293M -$1.000M $6.253M
YoY Change -136.67% -127.78% -493.02%
Pretax Income $13.96M -$14.30M -$148.0M
YoY Change -109.43% -90.8% -1174.68%
Income Tax $5.358M -$5.300M -$56.93M
% Of Pretax Income 38.39%
Net Earnings $8.400M -$9.600M -$91.10M
YoY Change -109.22% -91.01% -1020.2%
Net Earnings / Revenue 2.8% -3.18% -30.24%
Basic Earnings Per Share $0.26 -$0.30 -$2.89
Diluted Earnings Per Share $0.26 -$0.30 -$2.89
COMMON SHARES
Basic Shares Outstanding 32.47M shares 32.46M shares 31.51M shares
Diluted Shares Outstanding 32.93M shares 31.51M shares

Balance Sheet

Concept 2014 Q3 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.500M $17.30M $43.60M
YoY Change -87.39% 19.31% 11.51%
Cash & Equivalents $5.542M $17.30M $43.63M
Short-Term Investments
Other Short-Term Assets $34.00M $10.79M $9.819M
YoY Change 246.27% -5.73% -52.42%
Inventory
Prepaid Expenses $10.67M $11.46M
Receivables $102.9M $111.1M $111.1M
Other Receivables $0.00 $5.700M $0.00
Total Short-Term Assets $142.4M $205.3M $234.4M
YoY Change -39.25% -0.25% 0.24%
LONG-TERM ASSETS
Property, Plant & Equipment $141.4M $159.0M $160.1M
YoY Change -11.66% 1.48% 6.05%
Goodwill $208.9M $208.1M
YoY Change -0.33% -43.37%
Intangibles $36.70M $42.33M
YoY Change -21.91% -18.53%
Long-Term Investments $23.20M
YoY Change
Other Assets $158.7M $26.28M $26.50M
YoY Change 498.85% 40.93% 56.23%
Total Long-Term Assets $539.8M $521.1M $520.2M
YoY Change 3.78% -0.7% -18.96%
TOTAL ASSETS
Total Short-Term Assets $142.4M $205.3M $234.4M
Total Long-Term Assets $539.8M $521.1M $520.2M
Total Assets $682.2M $726.4M $754.6M
YoY Change -9.59% -0.57% -13.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.36M $20.14M $24.36M
YoY Change -20.52% -30.97% 12.32%
Accrued Expenses $159.7M $57.57M $54.34M
YoY Change 193.89% 4.95% -15.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.00M $13.90M $34.90M
YoY Change -65.62% -61.18% -35.74%
Total Short-Term Liabilities $191.1M $312.4M $332.5M
YoY Change -42.53% 52.56% 43.65%
LONG-TERM LIABILITIES
Long-Term Debt $102.3M $33.00M $36.00M
YoY Change 184.17% -50.67% -46.95%
Other Long-Term Liabilities $5.748M $8.511M $8.297M
YoY Change -30.72% 82.21% 87.25%
Total Long-Term Liabilities $108.0M $41.51M $44.30M
YoY Change 143.92% -42.0% -38.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $191.1M $312.4M $332.5M
Total Long-Term Liabilities $108.0M $41.51M $44.30M
Total Liabilities $299.1M $353.9M $376.8M
YoY Change -20.61% 28.07% 24.04%
SHAREHOLDERS EQUITY
Retained Earnings -$73.92M -$77.56M -$67.93M
YoY Change 8.81% -516.61% -154.16%
Common Stock $467.9M $463.0M
YoY Change 3.79% 3.75%
Preferred Stock
YoY Change
Treasury Stock (at cost) $18.18M $18.08M
YoY Change 6.19% 6.14%
Treasury Stock Shares 959.0K shares 875.0K shares 868.9K shares
Shareholders Equity $383.8M $372.2M $377.0M
YoY Change
Total Liabilities & Shareholders Equity $682.2M $726.4M $754.6M
YoY Change -9.59% -0.57% -13.83%

Cashflow Statement

Concept 2014 Q3 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income $8.400M -$9.600M -$91.10M
YoY Change -109.22% -91.01% -1020.2%
Depreciation, Depletion And Amortization $6.500M $8.700M $9.000M
YoY Change -27.78% -13.86% -9.09%
Cash From Operating Activities $25.40M $8.400M $27.90M
YoY Change -8.96% -46.15% 27.98%
INVESTING ACTIVITIES
Capital Expenditures -$800.0K -$12.70M -$9.400M
YoY Change -91.49% -21.12% -21.67%
Acquisitions
YoY Change
Other Investing Activities $1.000M $1.800M -$1.900M
YoY Change -152.63% -150.0% 375.0%
Cash From Investing Activities $200.0K -$11.00M -$11.30M
YoY Change -101.77% -44.44% -8.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -31.30M -23.70M -3.100M
YoY Change 909.68% 15.61% -58.67%
NET CHANGE
Cash From Operating Activities 25.40M 8.400M 27.90M
Cash From Investing Activities 200.0K -11.00M -11.30M
Cash From Financing Activities -31.30M -23.70M -3.100M
Net Change In Cash -5.700M -26.30M 13.50M
YoY Change -142.22% 6.48% 575.0%
FREE CASH FLOW
Cash From Operating Activities $25.40M $8.400M $27.90M
Capital Expenditures -$800.0K -$12.70M -$9.400M
Free Cash Flow $26.20M $21.10M $37.30M
YoY Change -29.76% -33.44% 10.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Pension Expense
PensionExpense
4682000
us-gaap Pension Expense
PensionExpense
6200000
amed Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
60
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
521000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1500000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5848000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1885000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8511000
us-gaap Cost Of Services
CostOfServices
519686000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
110000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
372201000
CY2013Q4 us-gaap Minority Interest
MinorityInterest
278000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
372479000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
726406000
us-gaap Costs And Expenses
CostsAndExpenses
894790000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6457000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.78
CY2014Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
4183000
CY2013Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
40308000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-139918000
us-gaap Operating Income Loss
OperatingIncomeLoss
-144609000
us-gaap Interest Expense
InterestExpense
2478000
us-gaap Cost Of Services
CostOfServices
538660000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
945847000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
28306000
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-90336000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-733000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3974000
amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
150000000
CY2014Q3 amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
0
CY2013Q3 amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
150000000
amed Us Department Of Justice Settlement
UsDepartmentOfJusticeSettlement
0
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4174000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6357000
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
467890000
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
191065000
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
102299000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5748000
CY2014Q3 us-gaap Liabilities
Liabilities
299112000
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
33000000
CY2013Q4 us-gaap Liabilities
Liabilities
353927000
CY2013Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
33000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
18176000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77561000
CY2014Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
34000
CY2014Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-100000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-300000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57572000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73920000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
224032000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
904026000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5358000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-91069000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
682213000
us-gaap Share Based Compensation
ShareBasedCompensation
3197000
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
142066000
CY2014Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25370000
CY2013Q4 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
60000
CY2014Q3 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
0
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
19363000
CY2014Q3 amed Accrued Charge Related To Us Department Of Justice Settlement
AccruedChargeRelatedToUsDepartmentOfJusticeSettlement
35000000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
10153000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
55329000
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
90214000
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
959025 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34306877 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
128478000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
159025000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
141419000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
13318000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
22109000
us-gaap Operating Income Loss
OperatingIncomeLoss
9236000
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25133000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
14231000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
129891000
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
874999 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33413970 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32538971 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15640000
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
110240000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2483000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-216000
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.26
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.87
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.12
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.73
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Labor And Related Expense
LaborAndRelatedExpense
228758000
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.26
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.87
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.12
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.73
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
284033000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
8439000
CY2014Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
6515000
CY2014Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
32018000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
8597000
CY2014Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
24000
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1697000
CY2013Q3 us-gaap Interest Expense
InterestExpense
672000
CY2014Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
69461000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
158000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16248000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13955000
CY2014Q3 us-gaap Cost Of Services
CostOfServices
170159000
CY2014Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
300281000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
563000
CY2014Q3 us-gaap Interest Expense
InterestExpense
2990000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
455511000
CY2013Q3 us-gaap Cost Of Services
CostOfServices
175233000
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1653000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-733000
CY2013Q3 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
8925000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-147973000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-91778000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-56928000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
354000
CY2013Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
18000
CY2013Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
73906000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6553000
CY2013Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
301285000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-154226000
CY2013Q3 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
3944000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
40000
us-gaap Share Based Compensation
ShareBasedCompensation
4933000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
12437000
us-gaap Net Income Loss
NetIncomeLoss
-86549000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-53736000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1615000
us-gaap Costs And Expenses
CostsAndExpenses
1090456000
us-gaap Profit Loss
ProfitLoss
-87797000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6075000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1054000
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-216000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3857000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1615000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-84934000
CY2014Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
8597000
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8439000
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-91045000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-86182000
CY2014Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2013Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1542000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
2208000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
3828000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2293000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6253000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2779000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4691000
us-gaap Interest Paid
InterestPaid
2384000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-53611000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
93000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1239000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
258000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
128000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1409000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1554000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
668000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4081000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70129000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
9000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9882000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
104000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9162000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
89000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1875000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10904000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67530000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11761000
us-gaap Interest Paid
InterestPaid
4771000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2069000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3235000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8111000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11198000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28983000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
93862000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
548000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43626000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29325000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
627000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2436000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31856000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
975000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-45170000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14545000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12853000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13392000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
126000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28730000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
9732000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
3421000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
200800000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25500000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2762000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3625000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
-1549000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
312000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
3725000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
4233000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
190800000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25500000
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32690000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31102000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
496000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
640000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32194000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31102000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32934000 shares
CY2014Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0
CY2013Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35456000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
0
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
163000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1808000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
2967000
amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
488000
amed Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
0
amed Increasedecreaseinusdepartmentofjusticesettlementaccrual
Increasedecreaseinusdepartmentofjusticesettlementaccrual
150000000
amed Increasedecreaseinusdepartmentofjusticesettlementaccrual
Increasedecreaseinusdepartmentofjusticesettlementaccrual
-115000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
901000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
67371000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2014Q3 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5 pure
CY2014Q3 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.2 pure
CY2014Q3 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP. In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> condensed</font><font style="font-family:Times New Roman;font-size:10pt;"> consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p>
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:6pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;">and Comparability </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications have been made to prior period's financial statements in order to conform to the current period's presentation</font><font style="font-family:Times New Roman;font-size:10pt;">.</font></p><p style='margin-top:6pt; margin-bottom:0pt'>&#160;</p>
CY2014Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 States
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
CY2014Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
103200000
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
CY2014Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.81 pure
CY2013Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.84 pure
CY2013Q4 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2013Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
11900000
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1 pure
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
4100000
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
CY2013 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.67 pure
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
9100000
CY2014Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.96 pure
CY2013Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
1.00 pure
CY2013Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2500000
CY2014Q3 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
1400000
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2014Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
114300000
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
682000 shares
CY2014Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
466000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
107000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32468000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31505000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31505000 shares
CY2014Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2014Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
7700000
CY2013Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1200000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
-300000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-2700000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1100000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
27200000
CY2014Q1 amed Number Of Care Centers Included In Divestiture Plan
NumberOfCareCentersIncludedInDivestiturePlan
43 Agencies
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
46900000
CY2014Q3 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.8 pure
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
102300000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
33000000
CY2014Q3 amed Total Leverage Ratio
TotalLeverageRatio
2.1 pure
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
114300000
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
120000000
CY2014Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
165000000
CY2014Q3 amed Senior Secured Leverage Ratio
SeniorSecuredLeverageRatio
1.2 pure
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
amed Medicare Revenue
MedicareRevenue
4000000
amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
115000000
amed Final Payment Of Us Department Of Justice Settlement
FinalPaymentOfUsDepartmentOfJusticeSettlement
35000000
amed Payment Upon Execution Of Us Department Of Justice Settlement
PaymentUponExecutionOfUsDepartmentOfJusticeSettlement
116500000
CY2014Q1 amed Relators Attorneys Fees For Us Department Of Justice Settlement
RelatorsAttorneysFeesForUsDepartmentOfJusticeSettlement
3900000
amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
amed Final Payment Of Us Department Of Justice Settlement
FinalPaymentOfUsDepartmentOfJusticeSettlement
35800000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
337500000
CY2013Q3 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
116000000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
357200000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 Segments

Files In Submission

Name View Source Status
0001193125-14-386631-index-headers.html Edgar Link pending
0001193125-14-386631-index.html Edgar Link pending
0001193125-14-386631.txt Edgar Link pending
0001193125-14-386631-xbrl.zip Edgar Link pending
amed-20140930.xml Edgar Link completed
amed-20140930.xsd Edgar Link pending
amed-20140930_cal.xml Edgar Link unprocessable
amed-20140930_def.xml Edgar Link unprocessable
amed-20140930_lab.xml Edgar Link unprocessable
amed-20140930_pre.xml Edgar Link unprocessable
d787955d10q.htm Edgar Link pending
d787955dex311.htm Edgar Link pending
d787955dex312.htm Edgar Link pending
d787955dex321.htm Edgar Link pending
d787955dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g787955fslogo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending